These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11762704)

  • 1. Leptin levels in diabetic and nondiabetic subjects.
    Tatti P; Masselli L; Buonanno A; Di Mauro P; Strollo F
    Endocrine; 2001 Aug; 15(3):305-8. PubMed ID: 11762704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents.
    Huang KC; Lin RC; Kormas N; Lee LT; Chen CY; Gill TP; Caterson ID
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):470-5. PubMed ID: 14993909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between plasma leptin and anthropometric and metabolic covariates in lean and obese diabetic and hyperlipidaemic Asian Northern Indian subjects.
    Misra A; Arora N; Mondal S; Pandey RM; Jailkhani B; Peshin S; Chaudhary D; Saluja T; Singh P; Chandna S; Luthra K; Vikram NK
    Diabetes Nutr Metab; 2001 Feb; 14(1):18-26. PubMed ID: 11345162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.
    Panarotto D; Ardilouze JL; Tessier D; Maheux P
    Metabolism; 2000 Aug; 49(8):1055-62. PubMed ID: 10954026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus.
    Gulturk S; Cetin A; Erdal S
    Saudi Med J; 2008 Jun; 29(6):813-20. PubMed ID: 18521457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients: no effect of apolipoprotein E polymorphism.
    Wauters M; Considine R; Löfgren A; Van Broeckhoven C; Van der Auwera JC; De Leeuw I; Van Gaal L
    Metabolism; 2000 Jun; 49(6):724-30. PubMed ID: 10877196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of leptin with type 2 diabetes in non-obese subjects.
    Kazmi A; Tariq KM; Hashim R
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):186-9. PubMed ID: 24669650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans.
    Sumner AE; Falkner B; Kushner H; Considine RV
    Obes Res; 1998 Mar; 6(2):128-33. PubMed ID: 9545019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines.
    Sambataro M; Perseghin G; Lattuada G; Beltramello G; Luzi L; Pacini G
    Acta Diabetol; 2013 Jun; 50(3):301-7. PubMed ID: 22215127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between serum leptin, proinsulin, true insulin levels and insulin resistance in non-diabetic subjects: a population-based study].
    Li M; Zhan Z; Wu C; Yang J; Zhang K; Li X; Gan L
    Zhonghua Nei Ke Za Zhi; 2002 Nov; 41(11):754-7. PubMed ID: 12485522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
    Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample.
    Franco L; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G
    Metabolism; 2013 Aug; 62(8):1081-7. PubMed ID: 23477808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of tumor necrosis factor alpha and leptin in obesity and insulin resistance].
    Sun Q; Yang GH; Wang H
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):514-7. PubMed ID: 16080843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus.
    Milewicz A; Mikulski E; Bidzińska B
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S152-3. PubMed ID: 10997641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.